SCHEMBL6013595

SCHEMBL6013595

CCN1C(=O)C(=O)[N]c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.46
HSD17B10 Q99714 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
CASP1 P29466 1/20 0.44
MPI P34949 1/20 0.44
CACNA1B Q00975 1/20 0.44
APBA1 Q02410 1/20 0.44
MAPT P10636 3/20 0.42
TP53 P04637 2/20 0.42
HTT P42858 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NPC1 O15118 1/20 0.39
CYP1A2 P05177 1/20 0.39
GLA P06280 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4753186 0.81 ALDH1A1 (0.41) ALDH1A1HSD17B10SMN1; SMN2HPGDCASP1
SCHEMBL7436460 0.81 ALDH1A1 (0.41) ALDH1A1HSD17B10SMN1; SMN2HPGDCASP1
SCHEMBL8555900 0.78 CA12 (0.50) ALDH1A1HSD17B10HPGDMAPTKDM4E
SCHEMBL29064856 0.77 ALDH1A1 (0.40) ALDH1A1HSD17B10SMN1; SMN2HPGDTP53
SCHEMBL6013602 0.76 TTR (0.47) ALDH1A1HPGDMAPTKDM4ENPC1
SCHEMBL9034857 0.72 AADAT (0.36) ALDH1A1KDM4E
SCHEMBL8559311 0.72 TLR9 (0.31) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL4750501 0.71 ADRA2A (0.44) ALDH1A1MAPTHTTKDM4ECYP1A2
SCHEMBL22473980 0.71 ALDH1A1 (0.65) ALDH1A1HSD17B10SMN1; SMN2HPGDCASP1
SCHEMBL2228228 0.70 OPRL1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1711184-A1 (3-OXO-3,4-DIHYDRO-QUINOXALIN-2-YL-AMINO)-BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS GLYCOGEN PHOSPHORYLASE INHIBITORS FOR THE TREATMENT OF DIABETES AND OBESITY JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-18 EP disclosed
WO-2005067932-A1 (3-OXO-3, 4-DIHYDRO-QUINOXALIN-2-YL-AMINO) -BENZAMIDE DERIVATIVES AND RELATED COMPOUND AS GLYCOGEN PHOSPHORYLASE INHIBITORS FOR THE TREATMENT OF DIABETES AND OBESITY JANSSEN PHARMACEUTICA, N.V. (BE) 2005-07-28 WO disclosed